Anemia prevalence in CRC patients varies between 30 % and 75 % [50], with 25 % of CRC patients being diagnosed with moderate-severe anemia (Hb < 10 g/dL) [51]. The gene discussed is GSTM1; the disease is colorectal carcinoma.